Compare Bills

Primary Sponsor

Last Action

Ref to the Com on Appropriations, if favorable, Rules, Calendar, and Operations of the House2026-04-29

Vote Breakdown

No floor votes recorded.

Plain Language Summary

This bill appropriates a total of $34.25 million to support North Carolina's life sciences and biotechnology sectors, including funding for small business accounts, the Biotechnology Center, and a new reserve fund for emerging life science technologies. It also reorganizes the Advisory Council on Rare Diseases by moving it from UNC Chapel Hill to the Department of Health and Human Services, expanding its membership, and authorizing water and sewer infrastructure reimbursements for major manufacturing investments.

Arguments in Favor

• •Supporters argue this bill strengthens North Carolina's position in the competitive life sciences industry by providing sustained funding for research, workforce development, and economic development initiatives.
• •The legislation attracts major manufacturers by offering infrastructure support for businesses making substantial private investments ($2 billion) and creating high-wage jobs (500+), while the Advisory Council on Rare Diseases expansion increases representation from patients, caregivers, and industry experts to improve diagnosis and treatment of rare diseases.

Arguments Against

• •Opponents may contend that the $50 million water and sewer reimbursement program represents a significant state commitment with limited accountability mechanisms, as Governor's Letters become binding obligations without requiring future legislative appropriation.
• •Critics could also question whether the $20 million reserve fund for biomanufacturing technologies represents an appropriate use of state funds or if these investments should rely more on private sector financing, and whether the expanded rare diseases council structure adds administrative complexity without guaranteeing improved outcomes.